NCT01724593

Brief Summary

Intensive Care Unit-acquired weakness (ICU-AW) is a well-recognized, important and preventable sequelae of critical illness, affecting up to 60% of adult ICU patient. ICU-AW is associated with increased mortality and length of stay, and negatively impacts long-term functional outcomes and quality of life in affected patients and their caregivers. While delayed mobilization adversely affects clinical outcomes, early rehabilitation in the critically ill adult population is safe, feasible, cost effective, results in more ventilator free-days and better functional outcomes at hospital discharge. In contrast, there is a paucity of this research in pediatrics. Our research suggests that immobilization is common in critically ill children, and rehabilitation is delayed particularly in the sickest children who are arguably at highest risk of morbidity. It is unclear however, whether delayed rehabilitation leads to adverse outcomes in critically ill children, as has been demonstrated in adults. Our objectives of this study are to evaluate if immobilization and delayed rehabilitation negatively impacts short-term clinical outcomes and the time to functional recovery in critically ill children. The investigators hypothesize that the following factors may influence functional recovery and morbidity in critically ill children:

  • Pre-morbid condition
  • Age
  • Time-to-initiation of acute rehabilitation
  • Critical illness disease severity

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

October 30, 2012

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 12, 2012

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

November 5, 2013

Status Verified

November 1, 2013

Enrollment Period

1.1 years

First QC Date

October 30, 2012

Last Update Submit

November 3, 2013

Conditions

Keywords

functional recovery, critical illness, pediatrics

Outcome Measures

Primary Outcomes (1)

  • Feasibility

    Feasibility will be determined by the consent and enrolment rate, and the protocol adherence and follow-up rates.

    12 months

Secondary Outcomes (4)

  • Functional Recovery

    Baseline, 3 and 6 month follow-up

  • Pediatric Critical care Unit (PCCU) clinical outcomes

    at 30 days and duration of hospitalization

  • Muscle Strength

    Hospital discharge and at 3 and 6 month follow-up

  • Parental or caregiver stress

    3 month follow-up

Other Outcomes (1)

  • Feasibility and reliability of screening for PCCU-acquired weakness

    Duration of Hospitalization, 3 and 6 months follow-up

Study Arms (1)

Observational Cohort

No Intervention

Eligibility Criteria

Age12 Months - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Critically Ill Children

You may qualify if:

  • Age over 12 months to 17 years
  • PCCU stay of ≥ 48 hours
  • Patient is limited to bed-rest and has not been mobilized during the first 48 hours of PCCU admission
  • Equal to or greater than one organ dysfunction on PCCU admission (as measured by PELOD)
  • Informed consent of patient/substitute decision maker.

You may not qualify if:

  • Age: \< 12 months or ≥18 years
  • Patients admitted to step-down/intermediate care
  • Patients transferred from Neonatal intensive care unit and never discharge home.
  • iv) Patients who are already mobilizing well, or are at baseline functional status at time of screening v) Admission diagnosis of a neuromuscular disorder: e.g. Acute Guillain-Barré Syndrome, Botulism, Myasthenia Gravis), or acute spinal cord injury/transverse myelitis vi) Not expected to survive PCCU/hospital stay vii) Previously enrolled into study less than 6 months ago and/or still undergoing study procedures at time of screening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McMaster Children's Hospital

Hamilton, Ontario, L8N 3Z5, Canada

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Karen Choong, MB, BCh, MSc

    McMaster University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 30, 2012

First Posted

November 12, 2012

Study Start

October 1, 2012

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

November 5, 2013

Record last verified: 2013-11

Locations